Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia

[1]  J. Cummings,et al.  Disease-modifying therapies in Alzheimer’s disease ⁎ ⁎ EDITOR’S NOTE: The Journal intended to include this article in the January 2008 supplement, “Leon Thal Symposium on Prevention of Dementia.” , 2008, Alzheimer's & Dementia.

[2]  I. Shapira.  The Nun Study. , 2008, Journal of the American Dental Association.

[3]  Karen Ritchie,et al.  Is Antioxidant Therapy a Viable Alternative for Mild Cognitive Impairment? Examination of the Evidence , 2007, Dementia and Geriatric Cognitive Disorders.

[4]  J. Morris,et al.  Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease , 2001, Journal of Molecular Neuroscience.

[5]  C. Jack,et al.  Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.

[6]  C. Jack,et al.  Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment , 2007, Journal of Molecular Neuroscience.

[7]  J. O'Brien,et al.  Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology , 2006, Journal of psychopharmacology.

[8]  P. Scheltens,et al.  Impact of White Matter Hyperintensities Scoring Method on Correlations With Clinical Data: The LADIS Study , 2006, Stroke.

[9]  F Barkhof,et al.  Is the whole brain periventricular? , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[10]  A. Verma.  Cerebral White Matter Lesions and the Risk of Dementia , 2006 .

[11]  M. Hüll,et al.  Disease-modifying therapies in Alzheimer's disease: how far have we come? , 2006, Drugs.

[12]  Charles DeCarli,et al.  Different mechanisms of episodic memory failure in mild cognitive impairment , 2005, Neuropsychologia.

[13]  D. Marcus,et al.  White matter lesions are prevalent but differentially related with cognition in aging and early Alzheimer disease. , 2005, Archives of neurology.

[14]  M. Woodward,et al.  Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.

[15]  D. Bennett,et al.  Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.

[16]  L. Thal,et al.  A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment , 2005, Neuropsychopharmacology.

[17]  D. Harvey,et al.  Anatomical Mapping of White Matter Hyperintensities (WMH): Exploring the Relationships Between Periventricular WMH, Deep WMH, and Total WMH Burden , 2005, Stroke.

[18]  R. Egan,et al.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia , 2005 .

[19]  D. W. Desmond,et al.  The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? , 2004, Journal of the Neurological Sciences.

[20]  O. Hanon,et al.  Prevention of dementia: lessons from SYST-EUR and PROGRESS , 2004, Journal of the Neurological Sciences.

[21]  R. Petersen.  Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.

[22]  S. Salloway,et al.  Efficacy of donepezil in mild cognitive impairment , 2004, Neurology.

[23]  H. C. Chui,et al.  White matter lesions impair frontal lobe function regardless of their location , 2004, Neurology.

[24]  S. DeKosky,et al.  Mild cognitive impairment, amnestic type , 2004, Neurology.

[25]  W. M. van der Flier,et al.  Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD , 2004, Neurology.

[26]  J. Schneider,et al.  Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology , 2004, Neurology.

[27]  C. Jack,et al.  Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. , 2004, Archives of neurology.

[28]  John Breitner,et al.  Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. , 2003, Archives of neurology.

[29]  C. DeCarli.  The Role of Cerebrovascular Disease in Dementia , 2003, The neurologist.

[30]  Heping Zhang,et al.  Basal Ganglia volumes in patients with Gilles de la Tourette syndrome. , 2003, Archives of general psychiatry.

[31]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[32]  J. C. Torre,et al.  Vascular Basis of Alzheimer's Pathogenesis , 2002 .

[33]  A. Hofman,et al.  Periventricular cerebral white matter lesions predict rate of cognitive decline , 2002, Annals of neurology.

[34]  C. Jack,et al.  Brain MRI hippocampal volume and prediction of clinical status in a mild cognitive impairment trial , 2002, Journal of Molecular Neuroscience.

[35]  D. A. Bennett,et al.  Natural history of mild cognitive impairment in older persons , 2002, Neurology.

[36]  W. Markesbery,et al.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study , 2002, Annals of neurology.

[37]  P. Scheltens,et al.  Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment , 2002, Journal of neurology, neurosurgery, and psychiatry.

[38]  E. Englund.  Neuropathology of White Matter Lesions in Vascular Cognitive Impairment , 2002, Cerebrovascular Diseases.

[39]  L. Launer.  Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.

[40]  P. Thomas,et al.  ALZHEIMER'S DISEASE AND VASCULAR FACTORS: FACTS AND THEORIES , 2002, International journal of clinical practice.

[41]  B L Miller,et al.  Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. , 2001, Archives of neurology.

[42]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[43]  H. Gertz,et al.  Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study , 2000, International journal of geriatric psychiatry.

[44]  L. Thal,et al.  Relationship between Severe Amyloid Angiopathy, Apolipoprotein E Genotype, and Vascular Lesions in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[45]  M. Samuel,et al.  Efficacy and Safety of OK-432 Sclerotherapy for Giant Cystic Hygroma in a Newborn , 2000, Fetal Diagnosis and Therapy.

[46]  R. Petersen,et al.  Mild cognitive impairment: transition between aging and Alzheimer's disease. , 2000, Neurologia.

[47]  C. DeCarli,et al.  Impact of Apolipoprotein E ε4 and Vascular Disease on Brain Morphology in Men From the NHLBI Twin Study , 1999 .

[48]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[49]  J. Morris,et al.  Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.

[50]  C. DeCarli,et al.  Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study. , 1999, Stroke.

[51]  M. Mesulam,et al.  Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. , 1998, Brain : a journal of neurology.

[52]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. , 1997, JAMA.

[53]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[54]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[55]  Dc Washington.  Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. , 1994 .

[56]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[57]  P. Scheltens,et al.  A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging , 1993, Journal of the Neurological Sciences.

[58]  P. Scheltens,et al.  Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[59]  Cummings Jl,et al.  Psychological dysfunction accompanying subcortical dementias. , 1988 .

[60]  D. Benson,et al.  Psychological dysfunction accompanying subcortical dementias. , 1988, Annual review of medicine.

[61]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[62]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.